Drag to reposition cover
About
The FDA De Novo classification pathway serves as an alternative to classify low-risk to medium-risk devices. Traditionally, these devices were automatically classified as Class III devices after the Food and Drug Administration determined during a review of the 510 (k) applications that they were not substantially equivalent.
Email: support@biotechresearchgroup.com
Call : (813) 333.2950
Visit : https://biotechresearchgroup.com/fda-de-novo/
Followers
(2)
Crop your avatar
